Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 15, 2024 (filed on Apr 16, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-3,598Price:$207.42
-
Apr 09, 2024 (filed on Apr 10, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Class A Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-5,000Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:4,480Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:17,920Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,715Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,564Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:8,145Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:10,692Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Schwenger Thomas D.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:7,636Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Schwenger Thomas D.Ownership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:30,544Price:--
Filings by filing date
-
Apr 15, 2024 (filed on Apr 16, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-3,598Price:$207.42
-
Apr 09, 2024 (filed on Apr 10, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Class A Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-5,000Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:4,480Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Faddis JonathanOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:17,920Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,715Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,564Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:8,145Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Epstein StaceyOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:10,692Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Schwenger Thomas D.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:7,636Price:--
-
Apr 05, 2024 (filed on Apr 05, 2024)Insider Name:Schwenger Thomas D.Ownership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:30,544Price:--
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 4280 Hacienda Drive PLEASANTON CA 94588 |
Tel: | 1-267-4605839 |
Website: | https://www.veeva.com/medtech |
IR: | See website |
Key People | ||
Thomas D. Schwenger President and Chief Customer Officer | E. Nitsa Zuppas President and Chief of Staff | Peter P. Gassner Chief Executive Officer, Director |
Timothy S. Cabral Interim Chief Financial Officer, Director | Alan V. Mateo Executive Vice President - Global Sales | Jonathan W. Faddis Senior Vice President, General Counsel, Corporate Secretary |
Kristine B. Diamond Principal Accounting Officer | Stacey Epstein Chief Marketing Officer |
Business Overview |
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company's three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass. |
Financial Overview |
For the fiscal year ended 31 January 2024, Veeva Systems Inc revenues increased 10% to $2.36B. Net income increased 8% to $525.7M. Revenues reflect Subscription services- R&D Solutions segment increase of 15% to $905.8M, Subscription services- Commercial Solutions segment increase of 5% to $995.8M, North America segment increase of 11% to $1.39B, Europe segment increase of 11% to $662.6M. |
Employees: | 7,172 as of Jan 31, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $28,161M as of Jan 31, 2024 |
Annual revenue (TTM): | $2,364M as of Jan 31, 2024 |
EBITDA (TTM): | $461.96M as of Jan 31, 2024 |
Net annual income (TTM): | $525.71M as of Jan 31, 2024 |
Free cash flow (TTM): | $885.14M as of Jan 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 161,316,597 as of Feb 29, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |